We sought to understand the genesis of the t(9;22) by characterizing genomic breakpoints in chronic myeloid leukemia (CML) and BCR-ABL-positive acute lymphoblastic leukemia (ALL). BCR-ABL breakpoints were identified in p190 ALL (n ¼ 25), p210 ALL (n ¼ 25) and p210 CML (n ¼ 32); reciprocal breakpoints were identified in 54 cases. No evidence for significant clustering and no association with sequence motifs was found except for a breakpoint deficit in repeat regions within BCR for p210 cases. Comparison of reciprocal breakpoints, however, showed differences in the patterns of deletion/insertions between p190 and p210. To explore the possibility that recombinase-activating gene (RAG) activity might be involved in ALL, we performed extra-chromosomal recombination assays for cases with breakpoints close to potential cryptic recombination signal sequence (cRSS) sites. Of 13 ALL cases tested, 1/10 with p190 and 1/3 with p210 precisely recapitulated the forward BCR-ABL breakpoint and 1/10 with p190 precisely recapitulated the reciprocal breakpoint. In contrast, neither of the p210 CMLs tested showed functional cRSSs. Thus, although the t(9;22) does not arise from aberrant variable (V), joining (J) and diversity (D) (V(D)J) recombination, our data suggest that in a subset of ALL cases RAG might create one of the initiating double-strand breaks.
Introduction
Chromosomal translocations that produce oncogenic fusion genes are common in hematological malignancies, but the mechanism by which they are formed is incompletely understood. Broadly there are three non-mutually exclusive factors that are believed to be relevant to this process: (i) biological selection for specific gene fusions or deregulated gene expression, 1 (ii) susceptibility of particular chromosomal regions to breakage 2 and (iii) the opportunity to recombine due to physical proximity. 3 Analysis to date has indicated that translocations in leukemia result from non-homologous end joining (NHEJ) following two double stranded DNA breaks; homologous recombination does not have a significant role. 4, 5 The paradigm for translocations in leukemia is the Philadelphia (Ph) chromosome, the smaller derivative of the t(9;22). 6 The resultant BCR-ABL fusion gene is the defining marker of chronic myeloid leukemia (CML). 6 In CML, the breakpoints in the majority of patients occur within the 5.8 kb major breakpoint cluster region (M-BCR) in the middle of BCR, resulting in a p210 BCR-ABL protein. The Ph chromosome is also found in 30% of adult acute lymphoblastic leukemia (ALL), 3-5% of childhood ALL and 1% of acute myeloid leukemia. 6 In contrast to CML, only about 30-50% of patients with Ph-positive ALL harbor the p210 fusion protein, with the remaining 50-70% being characterized by the smaller p190 fusion protein resulting from breakpoints in the BCR minor breakpoint cluster region (m-BCR) within the 72 kb BCR intron 1. Within ABL, most breaks fall within the 140 kb region between exon 1b and exon 2, however, in CML breaks upstream of exon 1b and between exons 2 and 3 also occur in some cases ( Figure 1 ). Despite this knowledge, the precise mechanism for the formation of the BCR-ABL fusion gene remains largely unknown. One of the reasons for this is that only a small number of genomic fusion junctions have been fully characterized, particularly for p190 for which only 2 breakpoints have been fully sequenced. 7, 8 Nevertheless, studies in CML have noted that BCR-ABL breakpoints are often associated with repeat regions. 5, 6, 9, 10 Also, it has been observed that BCR and ABL tend to be in close proximity compared with control genes during cell division in hematopoietic stem cells, potentially providing the opportunity for aberrant recombination should breakage occur. 3 The mechanisms behind many chromosomal translocations in lymphoid malignancies are clearer and are believed to be the result of the aberrant activity of the machinery for V(D)J or class switch recombination. 11, 12 In V(D)J recombination, which takes place early in B-cell differentiation, the recombinaseactivating gene (RAG) enzyme complex recognises specific recombination signal sequences (RSSs) flanking the V(D)J segments. RAG makes specific double stranded breaks that are subsequently ligated by NHEJ into a coding joint and a signal joint. The RAG complex can occasionally mistarget recombination to cryptic RSSs and juxtapose proto-oncogenes, such as LMO2 and HOX2, to loci that encode antigen receptors. [13] [14] [15] It is also possible for two non-antigen receptor loci to be joined erroneously by illegitimate V(D)J recombination, for example the SIL and SCL genes in some patients with T-ALL. 12, 16 In addition, in some B-cell lymphomas associated with Immunoglobulin H translocations, breakpoint regions adopting a non-B form might be mistargeted by RAG even in the absence of RSSs. 17 In CML it is thought that the transforming event takes place in a multipotent stem cell, inferred from the range of cell lineages that have been shown to be Ph or BCR-ABL positive. 18 In Ph-positive ALL, it is debated whether the acquisition of the Ph chromosome occurs in a multipotent stem cell, 19 -21 a committed lymphoid progenitor [22] [23] [24] or whether both are possible. 25 It has been suggested that p190 BCR-ABL might specifically direct lymphoid development, however, this fusion is seen occasionally in CML, 26 and in vivo experiments have shown that both p210 and p190 can give rise to CML or B-ALL depending on whether stem cells or committed progenitor cells are transduced. 27 It is possible, therefore, that the rarity of p190 in human CML is not a direct consequence of the activity of this fusion, but rather that BCR intron 1 breaks may be much more frequent in ALL because they are formed by a lymphoid-specific mechanism. 27 Such a mechanism could be the action of RAG, which is only present in lymphoid-restricted cells.
In this study we sought to characterize and compare breakpoint sequences in p210 CML, p210 ALL and p190 ALL to help clarify the mechanism giving rise to the t(9;22) in ALL. We aimed specifically to test the hypothesis that RAG-mediated recombination may have a role in the genesis of p190 BCR-ABL.
Materials and methods

Patient samples
Patients were randomly selected for analysis on the basis of sample availability (CML, n ¼ 32; p210 ALL, n ¼ 32; p190 ALL, n ¼ 43) from centers in the UK, Spain, Germany and Italy. The presence of e13a2 and/or e14a2 (p210) or e1a2 (p190) BCR-ABL fusion mRNA was determined by reverse transcriptase-PCR. 28 For samples with limited DNA, multiple displacement amplification (GenomiPhi, GE Healthcare, Amersham, UK) was undertaken according to the manufacturer's instructions. The study was approved by the Internal Review Boards from participating institutions and informed consent was provided according to the Declaration of Helsinki.
Detection of forward and reciprocal breakpoints
To sublocalise p190 BCR-ABL genomic breakpoints, fluorescence in situ hybridization was performed in some cases using fosmid clones selected from the Ensembl database (http:// www.ensembl.org) and obtained from the Sanger Institute (Hinxton, UK). The clones spanned BCR intron 1 and ABL exon 1b to a3 (clones E11, E8, G4, F1, D5; Supplementary Figure S1 ).
Fosmid clones were labelled and hybridized as previously described 29 after validation on normal control samples. For amplification of p190 and p210 breakpoints by long template PCR (LT-PCR) all primers were designed using Primer3 (http://frodo.wi.mit.edu/primer3/), checked to be free of singlenucleotide polymorphisms (http://genome.ucsc.edu/) and tested on normal control DNA with a suitable reverse primer. To amplify breakpoint bands up to 12 kb in size, the Expand LongTemplate LT-PCR system 2 (Roche, Burgess Hill, UK) was used with an annealing temperature of 64 1C and an elongation time of 8 min. Initially, a simplex (standard two primer) PCR protocol was used to detect both p190 and p210 breakpoints, however, a multiplex PCR strategy was later implemented, whereby every BCR forward primer was mixed with 5 ABL reverse primers (Supplementary Table S1 ). All breakpoint junctions amplified by LT-PCR were confirmed by reamplification from genomic DNA and sequencing across the breakpoint using an Applied Biosystems 3100 (Foster City, CA, USA). The reverse ABL primers were the same for the p210 and p190 screening, but the forward BCR primers were different. We attempted to identify reciprocal (ABL-BCR) breakpoints in all cases with characterized forward (BCR-ABL) breakpoints using ABL forward and BCR reverse primers approximately 2-4 kb either side of where the break was estimated to be. If no product was amplified after multiple attempts with multiple primer combinations, multiplex ligation-dependent probe amplification (MLPA) was used to detect large deletions, as previously described. 30 All nucleotide positions refer to NM_004327 and NM_007313 for BCR and ABL, respectively, with the A from the ATG start codon considered as position 1.
Statistical analysis
The Kolmogorov-Smirnov test was carried out to test for differences between the distributions of breakpoints in the different sub-types of BCR-ABL-positive leukemia. Scan statistics were used to detect any clustering of breakpoints and the Silverman's smoothed bootstrap test was then used to provide evidence for the numbers of clusters. The proximity of breakpoints to either known or unknown sequence motifs within 50 bp either side of the breaks were tested for by comparing the observed breakpoints to 200 randomly generated breakpoints. 31 In silico analysis of BCR-ABL forward breakpoints for cryptic RSSs Before functional analysis, the EMBOSS Fuzznuc tool (http:// bioweb.pasteur.fr/seqanal/interfaces/fuzznuc.html) was used to analyze all CML and ALL breakpoints to select the most likely candidates for illegitimate RAG activity. The search was configured using the consensus heptamer (5 0 -CACAGTG-3 0 ) and nonamer (5 0 -ACAAAAACC-3 0 ) sequences separated by 12 or 23 nucleotides. The CAC in the heptamer had to be present and up to nine mismatches were allowed in the remaining heptamer and nonamer sequences. 32, 33 Functional analysis of breakpoints to determine illegitimate RAG activity
The recombination plasmids used for the extra-chromosomal recombination assays have been described previously. 34 Briefly, the two fragments to be tested for V(D)J recombination are separated by a transcription stop sequence (oop). The P tac promoter will transcribe the chloramphenicol acetyltransferase gene when transformed into E.coli only when the stop signal has been previously deleted by recombination in eukaryotic cells. 34 Approximately 18 h before transfection, 1 Â 10 6 NIH-3T3 cells were plated onto 100 mm culture plates. For each transfection 2.5 mg of each plasmid (RAG-1, RAG-2, TdT and the test plasmid), 500 ml Opti-MEM (Invitrogen, Paisley, UK) and 40 ml of FuGene HD (Roche, Welwyn Garden City, UK) reagent were mixed according to the manufacturer's instructions. The FuGene: DNA complex was then added to the NIH-3T3 cells and after 40-48 h the plasmid DNA was extracted, transformed into E.coli, plated onto chloramphenicol and ampicillin plates. Colonies were plucked, amplified and sequenced. 34 For each experiment a positive control (RS32) 34 and no test plasmid control were included to ensure the assay was working correctly.
As each BCR-ABL cryptic recombination signal sequence (cRSS) could be used as either a signal or coding joint it was necessary to test the selected breakpoints for all possible putative combinations ( Figure 2 ) by using the authentic RSSs Dd2 (from the T-cell receptor alpha gene on chromosome 14q11.2). As these authentic sites had been previously tested and contained both 12 and 23 RSSs 34 and Dd2 was already supplied in the downstream cassette in both forward and inverse orientations (plasmids RS8 and RS24, respectively), 34 we generated two additional constructs that were called RS2 and RS3 (Dd2 inverse and forward in the upstream cassette, respectively), giving a total of four test constructs ( Figure 2 ). Each cRSS can potentially be used as either a 12 or 23 RSS and so there were two constructs required for each type of RSS (12, 23, forward or reverse). As many of the cases had more than one type of putative cRSS at or near the breakpoint a total of 43 constructs were made to test all permutations for the 15 cases that were selected for analysis. Breakpoint junctions (100-300 bp) were amplified by PCR from patient genomic DNA, incorporating appropriate restriction enzyme recognition sites into the primer sequences to facilitate subcloning. All constructs were resequenced to confirm their identity.
Results
Detection of forward p210 BCR-ABL genomic breakpoints
Two LT-PCR screens were developed to amplify forward p210 BCR-ABL breakpoints: (i) a multiplex assay consisting of eight individual reactions, each of which contained one (of two) forward BCR primer and five (of 20) reverse ABL primers and (ii) a simplex assay consisting of 40 individual reactions, each containing a single BCR primer and a single ABL reverse primer. Patients were screened initially with the multiplex assay, and if no product was amplified they were rescreened with the simplex assay. Amplified products were directly sequenced, usually with several internal BCR and ABL primers until the breakpoint was located and all breakpoints were confirmed by reamplification with specific primers from genomic DNA.
A total of 32 CML cases were analyzed that expressed e13a2 and/or e14a2 p210 mRNAs, and forward breakpoints were successfully identified in all cases. Of these, six were negative on the multiplex screen but positive by the simplex screen (Supplementary Table S2 ). A total of 32 p210 ALLs were also analyzed and breakpoints were successfully amplified from 25 (78%): 15 using the multiplex screen and 10 using the simplex screen (Supplementary Table S3 ).
Detection of forward p190 BCR-ABL breakpoints
Identification of p190 breakpoints is challenging because of the large size of the breakpoint cluster regions in both BCR and ABL. 
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Initially we pursued a fluorescence in situ hybridization strategy to sublocalize the breakpoints. Five fosmids were isolated (two within BCR intron 1 and three within ABL intron 1) that were used in pairwise combinations to identify the approximate breakpoint positions in five cases (Supplementary Figure S2) . This information was then used to direct LT-PCR screening, resulting in the successful identification of forward breakpoints for all five cases (#67, #68, #69, #70, #71). For many cases suitable cytogenetic material was not available and so we designed PCR screens on the basis of the strategy that had been successfully used for p210 cases. Initially a simplex LT-PCR screen was performed by combining 10 BCR forward spanning intron 1 and 10 ABL reverse primers (all ABL primers used were the same as for p210 screening). This screen consisted of 100 individual reactions per case and successfully amplified the breakpoints in 4 of 13 cases tested. An additional 10 ABL primers were designed and a multiplex LT-PCR strategy similar to p210 screening was implemented. The multiplex amplified one of nine cases that tested negative with the simplex screen and a further 9 of 25 cases, yielding a total of 19 breakpoints from 43 cases. All 19 p190 breakpoints within the BCR fell within the second half of intron 1 despite the fact that primers were equally spaced along the entire intron. To focus more specifically on this region, a further 11 BCR primers were designed and, in addition, 5 ABL primers upstream of exon 1b were also included. Inclusion of these primers in the multiplex assay resulted in the identification of six new breakpoints. In total, therefore, 25/43 (58%) of the p190 breakpoints were successfully amplified (Supplementary Table S4 ). A summary of the breakpoint analysis for all cases is shown on Table 1 .
Statistical analysis of forward breakpoints
In addition to the 82 BCR-ABL breakpoints found in this study, an additional 18 p210 CML forward breakpoints (Supplementary  Table S5 ) that had been identified by the same LT-PCR multiplex technique at a second center were used for the statistical analysis. No significant differences in the distribution of forward breakpoints between the different subtypes of leukemia or mRNA fusion were seen (Supplementary Table S6 ). Similarly no breakpoint clusters were observed, although some breakpoint preferences were apparent that approached statistical significance. For p210 ALL, two distinct broad clusters were seen, whereas for p210 CML these were less distinct (Figure 3a) . There was no clustering of p190 BCR breakpoints although, as noted above, it is striking that they all fell in the second half of BCR intron 1 (Figure 3b ). Within ABL there was a marginal excess of breakpoints towards the 3 0 end of the breakpoint cluster region for p190 ALL, whereas for p210 cases there were two broad clusters that were more pronounced when all cases were considered together (Figure 3c) .
In addition to clustering, the distributions of the breakpoints in BCR were directly compared with those in ABL for all p210 and p190 cases, however, no significant difference was found (see Supplementary Figure S3 ). To check whether the subsets of breakpoints were associated with known sequence motifs, including functional RSSs, the frequencies of specific sequence motifs (Supplementary Table S7 ) within 50 bp of sequence Analysis of BCR-ABL breakpoints J Score et al flanking the breakpoints were compared with those observed in the 50 bp flanking random breakpoints sampled from the entire BCR or ABL sequences. Only one significant association was found: a deficit of BCR breakpoints falling in repeat regions for p210 CML and all p210 cases considered as a single group (Supplementary Figure S4) . Undirected searches were also performed to see whether any unknown motifs were enriched 50 bp either side of the breakpoints. The only consistent result generated by this method was an association of CTGNNTTG with the BCR breakpoints in p210 ALL, however this motif has no known function and so the significance of this finding is unclear.
Structure of forward and reciprocal junction sequences for p210 and p190 cases Short stretches of microhomology (2-4 bp) at the forward breakpoints were found in 7/25 (28%) p190, 5/25 (20%) p210 ALL and 10/32 (31%) p210 CML. In addition, 2 p210 CMLs (#8 and #10) cases had microhomologies of 11 and 17 bp, respectively. To identify reciprocal breakpoints, LT-PCR was used to screen all 82 cases in which forward breakpoints had been found. This yielded 54 (66%) positive bands that were sequenced and confirmed. Of these, 21 were from cases with p210 CML (21/32; 66%), 12 with p210 ALL (12/25; 48%) and 21 with p190 ALL (21/25; 84%). Table 2 shows examples of different types of reciprocal breakpoints and Supplementary  Table S8 shows all the results. No products were obtained for the remaining 28 cases despite repeated attempts with multiple primer combinations.
Just seven cases had perfectly balanced translocations: three with p190 (#73, #74, #78), two with p210 ALL (#49, #53) and two with p210 CML (#2, #10). All other cases showed deletions, duplications or insertions at the breakpoints. Of the remaining 47 cases, 8 showed duplication of sequence derived from either or both genes (indicating staggered breaks incompatible with RAG-mediated activity), 28 had deletions and 11 had both duplications and deletions. The median number of duplicated nucleotides was 4 bp for the p190s (n ¼ 7, range 3-7 bp), 3 bp for the p210 ALLs (n ¼ 5, range 2-1000 bp) and 173 bp for the p210 CMLs (n ¼ 7, range 1-534 bp). The median size of deletions was 4 bp for p190s (n ¼ 15, range 1-27 bp), 24 bp for the p210 ALLs (n ¼ 8, range 1-7883 bp) and 29 bp for p210 CMLs (n ¼ 16, range 1-985 bp). All additional sequences at the reciprocal breakpoints could have been derived by duplication of neighboring sequences. In addition, two cases had insertions of unrelated sequence in their forward fusions. Case #65 (p190) had a complex rearrangement with an insertion of approximately 3 kb from chromosome 11. This was consistent with the karyotype that revealed a three-way translocation t(9;22;11)(q34;q11;p11), as well as several other abnormalities. The second case (#48; p210 ALL) had an Analysis of BCR-ABL breakpoints J Score et al insertion of 57 bp of intronic sequence from the phosphatidylserine decarboxylase gene, downstream of BCR. Neither of the reciprocal breakpoints was successfully amplified from these cases. Deletions of the 9q þ chromosome at the reciprocal breakpoint have been described in about 15% of CML cases. 30 To determine whether the failure to amplify reciprocal breakpoints was owing to the presence of large deletions, we performed MLPA analysis for 18 of the 28 of the reciprocal breakpoint-negative cases for whom adequate DNA was available. Eleven cases (CML, n ¼ 5; p210 ALL, n ¼ 5 and p190 ALL, n ¼ 1) showed deletion of at least two probes, indicating large deletions (Table 1; Supplementary Table S8) . Seven cases showed no deletion or deletion of just one probe (CML, n ¼ 4; p210 ALL, n ¼ 2 and p190 ALL, n ¼ 1). In addition, distances of the forward breakpoints from CpG and CAC/GTG sequences were analyzed (Supplementary Table S9 ), but no obvious differences were found between the different subtypes of leukemia.
Functional analysis of breakpoints
To determine whether RAG might have a role in the genesis of the t(9;22) we performed Fuzznuc analysis to identify candidate cRSS sequences close to the breakpoints. In total, 11/25 (44%) p190 ALL, 11/25 (40%) p210 ALL and 12/32 (38%) p210 CML forward breakpoints had candidate cRSSs, in which the start of the forward or reverse cryptic heptamer fell within 10 bp of the breakpoint (Supplementary Table S10 ). Cases with p190 ALL (n ¼ 10), p210 ALL (n ¼ 3) and p210 CML (n ¼ 2) were selected on the basis of proximity of the cRSS site to the breakpoint, as well as ensuring a mixture of both ABL and BCR sequences and a mixture of 12 and 23 cRSSs (Supplementary Table S11 ).
To test whether these candidate cRSS sequences could indeed act as RAG substrates we performed extra-chromosomal recombination assays using all relevant permutations. PCR and sequencing of the resulting colonies revealed that the high level of recombination events seen in the control vectors containing two pairs of authentic RSSs (RS32 and RS39) were indeed mediated by RAG (Supplementary Table S12 ). In contrast, the majority of colonies derived from BCR-ABL plasmids showed evidence of break repair (63% of all breakpoint-derived colonies) rather than RAG-mediated recombination. Of the colonies with potential RAG-mediated events, the great majority were non-specific with 44/49 BCR-ABL plasmids (24% of all colonies) using fortuitous RSS sites within the plasmid core DNA. There were a smaller number of non-breakpoint specific V(D)J recombination events (11% of all colonies; 33/49 of BCR-ABL plasmids) that arose from other fortuitous sites in either BCR or ABL. Altogether, this demonstrates the great sensitivity of our recombination substrate assay. Moreover, this indicates that a number of functional cRSS are present at random in a given sequence, including BCR and ABL breakpoint regions. The fact that such cryptic sites are not usually seen at BCR-ABL junctions indicates that standard V(D)J-mediated translocation is not a common event leading to the t(9;22).
Identification of 'specific' cRSSs at the breakpoints in four cases
Two cases, p210 ALL (#34) and p190 ALL (#64) recapitulated the exact forward breakpoint in a minority of colonies in at least two separate transfections. Case #34/RS2 yielded seven colonies (of 37 sequenced; 19%) that used the predicted 12 cRSS to make a signal joint (Figure 4a ) with six of these seven having the joint exactly at the breakpoint in ABL (the other colony had a signal joint with a 4 bp deletion in ABL). Case #64/RS3 yielded six colonies (of 43 sequenced; 14%) that used the predicted reverse 12 cRSS to make a coding joint. Of the six colonies, three recapitulated the exact forward breakpoint despite the breakpoint being 4 bp upstream of the putative cRSS (Figure 4b and Supplementary Figure S6) . Although there is larger than usual resection back into the signal end than might be expected by conventional V(D)J recombination, experiments in cells that lack some components of the NHEJ pathway show differences in the structures of breakpoints, such as larger deletions at the breakpoint. 35, 36 Both of these cases yielded multiple sequence variants in both transfections, usually with the addition of nontemplated nucleotides or small deletions around the breakpoint. In addition, case #62/RS8 yielded a signal joint 4 bp upstream of the BCR forward breakpoint, but co-incident with the reciprocal breakpoint (Supplementary Figure S5) .
Discussion
Although the t(9;22) was the first chromosomal abnormality to be associated with a hematological malignancy, 37 the mechanisms behind its formation and indeed those of many primary myeloid malignancies remains elusive. Sequence analysis of myeloid translocation breakpoints has revealed that the majority probably result from NHEJ following DNA breakage, 4, 33, 38, 39 however, the reason why some fusions are seen very frequently compared with other known or potential fusions is still unclear. By contrast, the mechanisms giving rise to many chromosomal translocations in lymphoid malignancies are believed to be the result of illegitimate lymphoid-specific recombination mechanisms, such as V(D)J 16, 34, 40, 41 or class switch recombination. 11, 42 In this study, we aimed to determine whether there were any consistent differences between t(9;22) breakpoints in CML and ALL, and to understand why the p190 fusion is nearly always associated with lymphoid disease. We characterized 82 forward BCR-ABL genomic breakpoints and 54 reverse ABL-BCR genomic breakpoints using LT-PCR and identified 11 cases with large 9q þ deletions by MLPA ( Table 1 ). The reasons why fewer breakpoints were successfully identified in ALL compared with CML are probably two-fold; (i) the quality and amount of DNA available for some ALL cases was less than that for CML and (ii) for p210 cases we identified several breakpoints by a simplex screen following the failure to amplify fusion junctions by multiplex PCR; for p190 the follow-up simplex screen was not performed because of the very large number of amplifications required for each case.
Statistical analysis did not reveal any differences in breakpoint distribution between the subtypes of leukemia, and only very weak evidence for clustering was observed. For p190, breaks in BCR were confined to the 3 0 end of intron 1, confirming Southern blot studies on a small number of Ph-positive, BCR-ABL-positive acute leukemias. 43 However, we found no evidence for any clustering within the m-BCR, contrary to previous reports that suggested subclustering of these breakpoints in Alu repeat regions. 10, 44 Analysis of sequence motifs found one significant association: a deficit of repeat regions in p210 BCR breakpoints. This contrasts with other publications that have indicated an association of repeats, particularly Alu elements, in both ABL and BCR. 5, 9 These previous observations, however, were made on small numbers of cases and may have been biased owing to the fact that the methodology used to amplify breakpoints required the presence of specific restriction enzyme recognition sites.
Amplification of the reciprocal breakpoints was more successful in p190 compared with p210 cases (21/25 versus 33/57; P ¼ 0.02, Fisher's exact test). This is consistent with previously published data generated by fluorescence in situ hybridization and reverse transcriptase-PCR showing that p190 cases had a much lower frequency of large 9q þ deletions, 45, 46 compared with the established figure of around 15% in CML. 47 Fine breakpoint mapping revealed that the sizes of deletions and duplications at the breakpoint junctions were smaller in p190 compared with p210 cases. Assuming that any LT-PCR-negative/ MLPA-negative cases had deletions that were too large to be detected by LT-PCR, but too small for MLPA, the median size of deletions was 6 bp for p190 and 7883 bp for p210. These data suggest that p190 and p210 are formed by different mechanisms. We did not observe any consistent difference between CML and p210 ALL breakpoints, but this is perhaps not unexpected as an unknown proportion of p210 ALLs may in fact be derived from early transformation of a CML clone. As previously described, we did not find large tracts of homology between ABL and BCR at the breakpoint junctions, but small deletions and duplications suggestive of NHEJ were frequent. Short stretches of microhomology (2-4 bp) at the forward breakpoints were found in 7/25 (28%) p190, 5/25 (20%) p210 ALL and 10/32 (31%) p210 CML. In addition, 2 p210 CMLs (#8 and #10) cases had microhomologies of 11 and 17 bp, respectively.
As p190 is largely restricted to lymphoid disease we considered the possibility that RAG may be involved in generating this fusion. The two hallmarks of V(D)J recombination are the addition of non-templated nucleotides and palindromic sequences, neither of which were observed in our cases. This does not, however, preclude the possibility that one or both breaks in ALL may be accomplished by aberrant RAG activity. We, therefore, searched for potential cRSS signals using previously defined criteria. 32, 33 Because of high degeneracy, these sequences are expected to occur on average every 5000 bp and, therefore, we identified several candidate ALL and CML cases. As it is not possible to predict the functionality of cRSSs on the basis of sequence alone, we selected a representative subset for analysis by the extra-chromosomal recombination assay. 34 Although no strong or recurrent RAG recognition sites were observed, it is striking that we found precise recapitulation of the forward breakpoint in two ALL cases multiple times in multiple transfections. Furthermore, one p190 ALL case was identified, with a cut site at the reciprocal breakpoint. By contrast specific cRSSs were not identified in the two CML cases tested.
Taken together, our data support the hypothesis that p190 and p210 BCR-ABL are formed by different mechanisms. In particular the presence of functional cryptic RSS sequences close to some ALL breakpoints suggests the involvement of RAG, which in turn indicates that these fusions must have arisen in a committed lymphoid progenitor cell; however, these were exceptional cases rather than the rule.
